up home page bottom

French German version Spanish version Italian version

header image

category archive listing Category Archives: Gardasil®

NVIC Says Government Denies Gardasil Risks

Posted by H. Sandra Chevalier-Batik

Vaccine Watchdog Group Calls for Transparency
WASHINGTON–(BUSINESS WIRE)–The National Vaccine Information Center (NVIC) is calling on the Centers for Disease Control (CDC) and Food and Drug Administration (FDA) to publicly release the study design, data and names of principal investigators involved in a statement this week maintaining that Gardasil vaccine is safe with no serious side [...]

More Questions About Gardasil®

Posted by H. Sandra Chevalier-Batik

A Recent CNN Article lead with this headline…
Gardasil® Deaths, Gardasil® Side Effects, Gardasil® Paralysis -
Is the HPV Vaccine Given to Prevent Cervical Cancer Causing More Medical Problems?
A vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems.
Gardasil® has been the subject of [...]

FDA Addresses Questions About Gardasil®

Posted by H. Sandra Chevalier-Batik

Those of you who are regular readers know that I think Gardasil® is the wrong solution for preventing Cervical Cancer. It is my considered opinion that Gardasil® has one purpose — it is a much needed cash cow for Merck, in their time of financial need.  My attempt at “Fair and Balanced” reporting is to [...]

Merck Wins Expanded Uses for Gardasil®

Posted by H. Sandra Chevalier-Batik

FDA News

FOR IMMEDIATE RELEASE
September 12, 2008

Media Inquiries:
Karen Riley, 301-827-6242
Consumer Inquiries:
888-INFO-FDA

FDA Approves Expanded Uses for Gardasil® to Include Preventing Certain Vulvar and Vaginal Cancers
The U.S. Food and Drug Administration today announced the approval of the vaccine Gardasil for the prevention of vaginal and [...]

Gardasil® — When Merketing Pre-empts Medicine

Posted by H. Sandra Chevalier-Batik

It is not hard to hear about Gardasil…
“In television advertisements, a cast of hip people in their 20s — artists, writers and professionals — describe why they got the shots, in the language of liberation, such as, “I chose to get vaccinated because my dreams don’t include cervical cancer.” The advertisements direct viewers to gardasil.com, [...]

Safe, Cost Effective PAP Test or Gardasil®

Posted by H. Sandra Chevalier-Batik

Researchers and public health officials are FINALLY waking up, and stepping up, to ask tough questions about the cost effectiveness of administering a very expensive, and not thoroughly vetted vaccine to every girl and young woman in the free world. Is the use of Gardasil® as a preventive measure against cervical cancer, the correct utilization [...]

Gardasil Financial Factoid

Posted by H. Sandra Chevalier-Batik

Follow The Money…
Merck has a growing economic interest in Virginia. In December 2006, Merck announced it would invest $57 million to expand its Elkton, Va., plant to make Gardasil, helped by a $700,000 grant from a state economic development agency that is part of the executive branch. Two months later, Gov. Tim Kaine, who has [...]

NY Times Exposes Merck Gardasil® Predatory Advertising Campaign

Posted by H. Sandra Chevalier-Batik

Opportunistic marketing isn’t new. Mass merchandising of tobacco products to minors delivered millions of “Hooked for Life” or at least until premature death ‘users” for BIG TOBACCO. With recent regulations that allegedly limited marketing tobacco to minors, rapacious advertising agencies and armies of mercenaries (lobbyists) have moved to a new, even more, profitable venue —BIG [...]

European Approach to HPV Testing and Treatment

Posted by H. Sandra Chevalier-Batik

Testing for HPV
Testing for human papillomavirus (HPV) may be a useful first step for cervical cancer screening in women younger than 35 years, preliminary findings indicate.
Testing for HPV is better than standard cell testing at picking up pre-cancerous changes, but it is also more likely to yield false results. This is particularly true among young [...]